Analysis of PTEN deletions and mutations in multiple myeloma

Leukemia Research

Volumn 30, Issue 3, 2006, Pages 262-265

  Chang, Hong ^a   Qi, Xiao Ying ^a   Claudio, Jaime ^a   Zhuang, Lihua ^a   Patterson, Bruce ^a   Stewart, A Keith ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

FISH; Multiple myeloma; PTEN; Tumor suppressor gene

Indexed keywords

MELPHALAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CELL CULTURE; CANCER STAGING; CELL CLONE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE INSERTION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HEMIZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELOMA CELL; PLASMA CELL; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; CELL LINE, TUMOR; CHROMOSOMES, HUMAN; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PTEN PHOSPHOHYDROLASE; RETROSPECTIVE STUDIES; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 30144433469     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.07.008     Document Type: Article

References (24)

1. H. Avet-Loiseau, C. Brigaudeau, and P. Talmant High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization Genes Chromosomes Cancer 24 1999 9 15
2. P.L. Bergsagel, and W.M. Kuehl Chromosome translocations in multiple myeloma Oncogene 20 2001 5611 5622
3. H. Chang, D. Bouman, N. Boerkoel, A.K. Stewart, and J. Squire Frequent Monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization Leukemia 13 1999 105 109
4. R. Konigsberg, N. Zojer, and J. Ackermann Predictive role of interphase cytogenetics for survival of patients with multiple myeloma J Clin Oncol 18 2000 804 812
5. N. Zojer, R. Konigsberg, and J. Ackmann Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization Blood 95 2000 1925 1930
6. J. Drach, J. Ackermann, and E. Fritz Presence of a p53 deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy Blood 92 1998 802 809
7. R. Fonseca, E. Blood, and M. Rue Clinical biologic implications of recurrent genomic aberrations in myeloma Blood 101 2003 4569 4575
8. H. Chang, C. Qi, Q.L. Yi, D. Reece, and A.K. Stewart P53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation Blood 105 2005 358 360
9. J. Li, C. Yen, and D. Liaw PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
10. P.A. Steck, M.A. Pershouse, and S.A. Jasser Identification of a candidate tumor suppressor gene MMACI at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat Genet 15 1997 356 362
11. M.P. Myers, J.P. Stolarov, and C. Eng PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphotase Proc. Natl. Acad. Sci. USA 94 1997 9052 9057
12. V. Stambolic, A. Suzuki, and J.L. de la Pompa Negative regulation of PKB/AKT-dependent cell survival by the tumor suppressor PTEN Cell 95 1998 29 39
13. N.L. Ge, and S. Rudikoff Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo Oncogene 19 2000 4091 4095
14. Y. Choi, J. Zhang, and C. Murga PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells Oncogene 21 2002 5289 5300
15. J. Zhang, Y. Choi, B. Mavromatis, A. Lichtenstein, and W. Li Preferential killing of PTEN-null myelomas by P13K inhibitors through Akt pathway Oncogene 22 2003 6289 6295
16. A. Sakai, C. Thieblemont, A. Wellmann, E. Jaffe, and M. Raffeld PTEN gene alterations in lymphoid neoplasms Blood 92 1998 3410 34154
17. M.P. Butler, S.I. Wang, Chaganati RSK, R. Parsons, and R. Dalla-Favera Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas Genes Chromosomes Cancer 24 1999 322 327
18. A. Aggerholm, K. Gronbck, P. Guldberg, and P. Hokland Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders Eur. J. Haematol. 65 2000 109 133
19. G.J. Ahmann, S.M. Jalal, and A.L. Juneau A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies Cancer Genet Cytogenet 101 1998 7 11
20. M. Chesi, E. Nardini, and L.A. Brents Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 Nat Genet 16 1997 260 264
21. M. Chesi, P.L. Bergsagel, and O.O. Shonukan Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma Blood 91 1998 4457 4463
22. H. Chang, S. Sloan, and L. Dan The t(4;14) is associated with a poor prognosis in multiple myeloma patients undergoing autologous stem cell transplant Bri J Haematol 125 2004 64 68
23. J.A. Esteban, M. Salas, and L. Blanco Fidelity of phi 29 DNA polymerase. Comparison between protein-primed initiation and DNA polymerisation J Biol Chem 268 1993 2719 2726
24. T.C. Liu, P.M. Lin, J.G. Chang, J.P. Lee, T.P. Chen, and S.F. Lin Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia Am J Hematol 63 2000 170 175